Clinical trial
Elucidating the High Cardiovascular Disease Risk in South Asians: Focus on Monocyte Phenotype and Incretin Hormones
NCT05829018 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Elucidating the High Cardiovascular Disease Risk in South Asians: Focus on Monocyte Phenotype and Incretin Hormones
- Lead sponsor
- Leiden University Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2023
- Completion date
- June 30, 2024
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.